Androski Lindsay
Arbutus Biopharma Corporation · President and CEO
Androski Lindsay is listed in public filings as director, officer: President and CEO. This Androski Lindsay insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Arbutus Biopharma Corporation (ABUS), and Eloxx Pharmaceuticals, Inc. (ELOX). Investors use Androski Lindsay's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $315k71.7k shares | Grant / ExerciseFeb 2, 2026 | $314.8K71.7k shares | $4.39 | -- | |
| --28k shares | Grant / ExerciseFeb 2, 2026 | Disclosure amount unavailable28k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $993k310.4k shares | Grant / ExerciseMar 18, 2025 | $993.4K310.4k shares | $3.20 | -- | |
| --3.8k shares | Grant / ExerciseJan 24, 2025 | Disclosure amount unavailable3.8k shares | -- | -- | |
| --12k shares | Grant / ExerciseOct 16, 2024 | Disclosure amount unavailable12k shares | -- | -- |